Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

v3.23.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total Jushi Shareholders' Equity
Common Stock
Subordinate Voting Shares
Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2021     182,707,359      
Balance at beginning of period at Dec. 31, 2021 $ 180,983 $ 182,370   $ 424,788 $ (242,418) $ (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Private placement offerings (in shares)     3,717,392      
Private placement offerings 13,680 13,680   13,680    
Shares issued for acquisition (in shares)     527,704      
Shares issued for acquisition 1,594 1,594   1,594    
Shares issued for restricted stock grants (in shares)     5,952      
Shares issued upon exercise of warrants (in shares)     2,676,303      
Shares issued upon exercise of warrants 9,693 9,693   9,693    
Shares issued upon exercise of stock options (in shares)     93,915      
Share-based compensation (including related parties) 6,964 6,964   6,964    
Net income (loss) (19,757) (19,757)     (19,757)  
Balance at end of period (in shares) at Mar. 31, 2022     189,728,625      
Balance at end of period at Mar. 31, 2022 193,157 194,544   456,719 (262,175) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2021     182,707,359      
Balance at beginning of period at Dec. 31, 2021 180,983 182,370   424,788 (242,418) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (7,691)          
Balance at end of period (in shares) at Jun. 30, 2022     194,653,132      
Balance at end of period at Jun. 30, 2022 224,096 225,483   475,592 (250,109) (1,387)
Balance at beginning of period (in shares) at Mar. 31, 2022     189,728,625      
Balance at beginning of period at Mar. 31, 2022 193,157 194,544   456,719 (262,175) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares issued for acquisition (in shares)     4,662,384      
Shares issued for acquisition 13,573 13,573   13,573    
Shares issued for service received (in shares)     101,082      
Shares issued for services received 294 294   294    
Shares issued upon exercise of warrants (in shares)     167,560      
Shares issued upon exercise of warrants 322 322   322    
Shares issued upon exercise of stock options (in shares)     1,294      
Shares canceled upon forfeiture of restricted stock, net of restricted stock grants (in shares)     (7,813)      
Share-based compensation (including related parties) 4,684 4,684   4,684    
Net income (loss) 12,066 12,066     12,066  
Balance at end of period (in shares) at Jun. 30, 2022     194,653,132      
Balance at end of period at Jun. 30, 2022 224,096 225,483   475,592 (250,109) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2022     196,686,372      
Balance at beginning of period at Dec. 31, 2022 45,891 47,278   492,020 (444,742) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Shares canceled upon forfeiture of restricted stock, net of restricted stock grants (in shares)     (53,001)      
Share-based compensation (including related parties) 2,311 2,311   2,311    
Net income (loss) (12,440) (12,440)     (12,440)  
Balance at end of period (in shares) at Mar. 31, 2023     196,633,371      
Balance at end of period at Mar. 31, 2023 35,762 37,149   494,331 (457,182) (1,387)
Balance at beginning of period (in shares) at Dec. 31, 2022     196,686,372      
Balance at beginning of period at Dec. 31, 2022 45,891 47,278   492,020 (444,742) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (26,476)          
Balance at end of period (in shares) at Jun. 30, 2023     196,633,371      
Balance at end of period at Jun. 30, 2023 27,480 28,867   500,085 (471,218) (1,387)
Balance at beginning of period (in shares) at Mar. 31, 2023     196,633,371      
Balance at beginning of period at Mar. 31, 2023 35,762 37,149   494,331 (457,182) (1,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Modification and reclassification of warrants 3,391 3,391   3,391    
Share-based compensation (including related parties) 2,363 2,363   2,363    
Net income (loss) (14,036) (14,036)     (14,036)  
Balance at end of period (in shares) at Jun. 30, 2023     196,633,371      
Balance at end of period at Jun. 30, 2023 $ 27,480 $ 28,867   $ 500,085 $ (471,218) $ (1,387)